People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| GRO Biosciences Inc. | — | Biotechnology | Series B | $33.3M | $191.9M | 2017 |
Geoffrey J Smith at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Geoffrey J Smith on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Geoffrey Smith | 1 | 5 |
| Kevin J. Bitterman | 1 | 2 |
| Ming J Fang | 1 | 1 |
| Bruce J Beutel | 1 | 1 |
| Dan J Becker | 1 | 1 |
| Tracey J Lodie | 1 | 1 |
| Daniel J Mandell | 1 | 1 |
| Rakhshita J Dhar | 1 | 1 |
| Daniel Mandell | 1 | 1 |
| Christopher Gregg | 1 | 1 |
| Christopher J Gregg | 1 | 1 |
| Dainel Mandell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.